Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis
Julio C. Chavez, Ariel Grajales, J. Sandoval-Sus, Elyce P. Turba, Lisa A. Nodzon, Angimar Uriepero, Mohammad Ammad-ud-din, E. Sahakian, R. Komrokji, L. Sokol, Frederick L Locke, Bijal Shah, Jeffrey Lancet, Eduardo M. Sotomayor, M. Kharfan-Dabaja, C. Bello, Javier Pinilla-Ibarz
{"title":"Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis","authors":"Julio C. Chavez, Ariel Grajales, J. Sandoval-Sus, Elyce P. Turba, Lisa A. Nodzon, Angimar Uriepero, Mohammad Ammad-ud-din, E. Sahakian, R. Komrokji, L. Sokol, Frederick L Locke, Bijal Shah, Jeffrey Lancet, Eduardo M. Sotomayor, M. Kharfan-Dabaja, C. Bello, Javier Pinilla-Ibarz","doi":"10.1016/j.clml.2024.02.001","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":503375,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"17 13","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lymphoma Myeloma and Leukemia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.clml.2024.02.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
